发明名称 New hydroxy alkyl indolocarbazole derivatives are glycogen synthase kinase GSK-3 inhibitors, useful for the treatment of diabetes, obesity, central nervous system disorders or normal cell apoptosis
摘要 Hydroxy alkyl indolocarbazole derivatives (I), their isomers and salts with acids and bases, are new. Hydroxy alkyl indolocarbazole derivatives of formula (I), their isomers and salts with acids and bases, are new. R1 and R2 = H, 1-6C alkyl, aralkyl, OH, hydroxyalkyl, dihydroxyalkyl, alkoxy, alkoxy alkyl, amino and aminoalkyl (amino may be substituted by one or two alkyl, aryl or aralkyl groups); Ra and Rb = 1-6C alkylene; X1, X2, and X3 = OH, 1-6C alkoxy, aryloxy, alkyl, amino, alkylamino, dialkylamino, halogen, alkylcarbonyloxy, or azido; X4 = methylidene or -Rc-X1-; and Rc = a bond or methylene. The aryl groups may be phenyl or naphthyl. Independent claims are also included for: (1) A pharmaceutical composition for the inhibition of glycogen synthase kinase (GSK-3), comprising (I); and (2) Preparation of (I).
申请公布号 FR2831169(A1) 申请公布日期 2003.04.25
申请号 FR20010013576 申请日期 2001.10.22
申请人 LES LABORATOIRES SERVIER 发明人 PRUDHOMME MICHELLE;MARMINON CHRISTELLE;MOREAU PASCALE;HICKMAN JOHN;PIERRE ALAIN;PFEIFFER BRUNO;RENARD PIERRE;BIZOT ESPIARD JEAN GUY
分类号 A61K31/7056;A61P3/04;A61P3/10;A61P25/00;A61P25/16;A61P25/28;A61P35/00;A61P43/00;C07H19/23;(IPC1-7):C07H19/23;A61K31/705 主分类号 A61K31/7056
代理机构 代理人
主权项
地址